{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/bone-soft-tissue-sarcoma-recognition-referral/management/referral-for-suspected-bone-soft-tissue-sarcoma-in-children-young-people/","result":{"pageContext":{"chapter":{"id":"0c156dc0-c7e2-5e4c-9dab-dc5aeff6db66","slug":"referral-for-suspected-bone-soft-tissue-sarcoma-in-children-young-people","fullItemName":"Scenario: Referral for suspected bone and soft tissue sarcoma in children and young people","depth":2,"htmlHeader":"<!-- begin field af7862e5-c0b5-487e-8aff-1e59f5e06477 --><h2>Scenario: Referral for suspected bone and soft tissue sarcoma in children and young people</h2><!-- end field af7862e5-c0b5-487e-8aff-1e59f5e06477 -->","summary":"Covers the referral of children and young people with suspected bone or soft tissue sarcoma.","htmlStringContent":"<!-- begin item 1d3106d6-09ba-4a28-8aee-a39eea431326 --><!-- begin field c9afcd4d-2f90-4ba4-8cce-acd900acbdb9 --><p>From birth to 24 years.</p><!-- end field c9afcd4d-2f90-4ba4-8cce-acd900acbdb9 --><!-- end item 1d3106d6-09ba-4a28-8aee-a39eea431326 -->","topic":{"id":"e4747ecc-d17a-5e2c-bd0c-69fc109a74f5","topicId":"6f65762b-a612-4ce9-80e5-ee8cb24f6dde","topicName":"Bone and soft tissue sarcoma - recognition and referral","slug":"bone-soft-tissue-sarcoma-recognition-referral","lastRevised":"Last revised in August 2020","chapters":[{"id":"edf8fdb6-68e6-5dac-916a-206d3893e4b8","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"0b6c5a9d-30a1-51f3-b16c-afbf78f00757","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f18ae9ed-24b3-5a8f-b9fa-aabc10e5ced7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"25f4d7d5-200e-50b1-b791-8478134bfee4","slug":"changes","fullItemName":"Changes"},{"id":"cee3f7fc-90f5-5bab-8b99-9ad854a538e7","slug":"update","fullItemName":"Update"}]},{"id":"69a11364-50c2-5893-ba48-bfc291fd9678","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"5941fcea-4bbf-5dbd-9c8b-4fffe5ff513c","slug":"goals","fullItemName":"Goals"},{"id":"82675336-6e84-5f8b-8ae2-b134dad3713d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"04ecd3ef-a02c-5cfe-857c-97bed1748869","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"19da7d85-1a17-5d25-99b1-16680fb8dad5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e7f50592-c92d-57c3-8c6a-cfe55345fd8f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"009b5c07-0fe5-557c-8a45-c7108109e1b5","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"c03fa4ab-14ef-53f1-9ac4-1e56c50d705d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a27bf635-6878-5608-8d61-f30c114978f7","slug":"presentation","fullItemName":"Presentation"},{"id":"62b4b53a-17f2-5696-98a7-4e7f3c9c3de7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"358d5300-5ab8-55bc-859a-9942fc31c4e2","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"ddf19e0c-fe9b-5f6c-afc9-9a4dd392dbc2","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"1f947dbd-c647-5adb-9201-f12c1c87035d","slug":"symptoms-suggestive-of-bone-soft-tissue-sarcoma","fullItemName":"Symptoms suggestive of  bone and soft tissue sarcoma"},{"id":"6862abd5-4206-520f-84ce-551b9804968c","slug":"primary-care-investigations-for-bone-soft-tissue-sarcoma","fullItemName":"Primary care investigations for bone and soft tissue sarcoma"}]},{"id":"110de2f9-5daa-5079-a41a-f825ae71373b","fullItemName":"Management","slug":"management","subChapters":[{"id":"9db4d7e1-010f-5499-ae69-91208825f7b3","slug":"referral-for-suspected-bone-soft-tissue-sarcoma-in-adults","fullItemName":"Scenario: Referral for suspected bone and soft tissue sarcoma in adults"},{"id":"0c156dc0-c7e2-5e4c-9dab-dc5aeff6db66","slug":"referral-for-suspected-bone-soft-tissue-sarcoma-in-children-young-people","fullItemName":"Scenario: Referral for suspected bone and soft tissue sarcoma in children and young people"}]},{"id":"a613a902-9172-5bf6-96a1-8005ef1e1891","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"849285c0-c49a-5974-b160-a00c41b27871","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"6d6ae6fc-a667-541c-95fe-a5a702055efb","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"2abec814-d80c-5b2b-8a04-3b8ffbfa5fe7","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7c763a93-7e4c-5cd8-bcd6-5b896bfbba34","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"10b065a8-9445-5a79-8d56-0772ea690539","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7b6299b1-4f46-5e17-96aa-6b432b5d3dd3","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1ed23bde-0b8f-50fb-b4c1-08008605ca0b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"110de2f9-5daa-5079-a41a-f825ae71373b","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"167df5ca-bb9a-5b41-927e-6089a253599e","slug":"referral-timelines","fullItemName":"Referral timelines","depth":3,"htmlHeader":"<!-- begin field 3f6c1e33-e044-4512-9609-96d90fa5cf9f --><h3>Referral timelines</h3><!-- end field 3f6c1e33-e044-4512-9609-96d90fa5cf9f -->","summary":null,"htmlStringContent":"<!-- begin item 1d90fd83-7d28-49fd-a7ec-5f2690fa0f0b --><!-- begin field b682497a-ba4f-41a6-9609-403906ad68f2 --><ul><li>The referral timelines referenced in the National Institute for Health and Care Excellence (NICE) guideline are as follows:<ul><li>Immediate: an acute admission or referral occurring within a few hours, or even more quickly if necessary.</li><li>Urgent: to happen/be performed within 2 weeks.</li><li>Very urgent: to happen within 48 hours.</li><li>Non-urgent: the timescale generally used for a referral or investigation that is not considered very urgent or urgent.</li><li>Suspected cancer pathway referral: the patient is seen within the national target for cancer referrals (2 weeks at the time of publication of the 2015 NICE guideline <em>Suspected cancer: recognition and referral</em>).</li></ul></li></ul><!-- end field b682497a-ba4f-41a6-9609-403906ad68f2 --><!-- end item 1d90fd83-7d28-49fd-a7ec-5f2690fa0f0b -->","subChapters":[{"id":"35017e93-1cbb-5f10-85a1-296c5270009f","slug":"basis-for-recommendation-b0c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field da76345f-349e-4f30-9527-834eca7c0ad2 --><h4>Basis for recommendation</h4><!-- end field da76345f-349e-4f30-9527-834eca7c0ad2 -->","summary":null,"htmlStringContent":"<!-- begin item b0c6e116-8a18-4aa7-8a2d-753b07c84828 --><!-- begin field b31d394d-0d88-4d1b-8f86-400741553e34 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field b31d394d-0d88-4d1b-8f86-400741553e34 --><!-- end item b0c6e116-8a18-4aa7-8a2d-753b07c84828 -->","subChapters":[]}]},{"id":"b34e2936-4800-5618-9958-ea0f0129b99e","slug":"referral-for-suspected-bone-sarcoma","fullItemName":"Referral for suspected bone sarcoma","depth":3,"htmlHeader":"<!-- begin field 999ab7d0-e041-4313-a376-a6b7012751c6 --><h3>When should I refer a child or young person with suspected bone sarcoma?</h3><!-- end field 999ab7d0-e041-4313-a376-a6b7012751c6 -->","summary":null,"htmlStringContent":"<!-- begin item 935e1190-4597-47a2-b8ce-a6b701274f3a --><!-- begin field 517a31d3-a16d-4514-bb4f-a6b7012751c6 --><ul><li><strong>Consider a very urgent referral, </strong>for an appointment within 48 hours, for specialist assessment for children and young people if an X-ray suggests the possibility of bone sarcoma (new NICE recommendation for 2015).<ul><li>Separate recommendations have been made for adults and for children and young people to reflect that there are different referral pathways. However, in practice young people (aged 16–24 years) may be referred using either an adult or children's pathway depending on their age and local arrangements.</li></ul></li><li><strong>Consider a very urgent direct access X-ray, </strong>to be performed within 48 hours, to assess for bone sarcoma in children and young people with unexplained bone swelling or pain (new NICE recommendation for 2015).</li></ul><!-- end field 517a31d3-a16d-4514-bb4f-a6b7012751c6 --><!-- end item 935e1190-4597-47a2-b8ce-a6b701274f3a -->","subChapters":[{"id":"bac9b603-bcd5-5477-98b5-df4b062c93c8","slug":"basis-for-recommendation-029","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field c318a730-7dd7-46ca-94e8-a6b701275228 --><h4>Basis for recommendation</h4><!-- end field c318a730-7dd7-46ca-94e8-a6b701275228 -->","summary":null,"htmlStringContent":"<!-- begin item 029d7a43-051c-4550-b4f3-a6b70127521a --><!-- begin field 632dd6fe-4058-4a9d-a6f9-a6b701275228 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 632dd6fe-4058-4a9d-a6f9-a6b701275228 --><!-- end item 029d7a43-051c-4550-b4f3-a6b70127521a -->","subChapters":[]}]},{"id":"5d116c48-67dc-5259-88ba-9e46e8d7dfde","slug":"referral-for-suspected-soft-tissue-sarcoma","fullItemName":"Referral for suspected soft tissue sarcoma","depth":3,"htmlHeader":"<!-- begin field bbd09f57-8403-4967-89b8-a6b70127731c --><h3>When should I refer a child or young person with suspected soft tissue sarcoma?</h3><!-- end field bbd09f57-8403-4967-89b8-a6b70127731c -->","summary":null,"htmlStringContent":"<!-- begin item 11363d24-bc43-4624-9250-a6b701277185 --><!-- begin field 0140463b-8384-4368-bb05-a6b70127731c --><ul><li><strong>Consider a very urgent direct access ultrasound scan, </strong>to be performed within 48 hours, to assess for soft tissue sarcoma in children and young people with an unexplained lump that is increasing in size (new NICE recommendation for 2015).</li><li><strong>Consider a very urgent referral, </strong>for an appointment within 48 hours, for children and young people if they have ultrasound scan findings that are suggestive of soft tissue sarcoma OR if ultrasound findings are uncertain and clinical concern persists (new NICE recommendation for 2015).</li><li>Separate recommendations have been made for adults and for children and young people to reflect that there are different referral pathways. However, in practice young people (aged 16–24 years) may be referred using either an adult or children's pathway depending on their age and local arrangements.</li></ul><!-- end field 0140463b-8384-4368-bb05-a6b70127731c --><!-- end item 11363d24-bc43-4624-9250-a6b701277185 -->","subChapters":[{"id":"eabc78f5-1a5a-52e1-821b-7376c523f491","slug":"basis-for-recommendation-f41","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 48893f8f-e2ab-43e5-a896-a6b701277321 --><h4>Basis for recommendation</h4><!-- end field 48893f8f-e2ab-43e5-a896-a6b701277321 -->","summary":null,"htmlStringContent":"<!-- begin item f41d039c-0579-4a8f-8a69-a6b701277321 --><!-- begin field aed7adfb-17e2-4043-8174-a6b701277321 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field aed7adfb-17e2-4043-8174-a6b701277321 --><!-- end item f41d039c-0579-4a8f-8a69-a6b701277321 -->","subChapters":[]}]},{"id":"25431ec8-9597-52b5-9b4c-6e3dd85425df","slug":"diagnostic-referral-process","fullItemName":"Diagnostic and referral process","depth":3,"htmlHeader":"<!-- begin field 773afbf6-61bf-49bd-81f8-2c4a94055472 --><h3>Diagnostic and referral process</h3><!-- end field 773afbf6-61bf-49bd-81f8-2c4a94055472 -->","summary":null,"htmlStringContent":"<!-- begin item 9b825484-f933-42f2-83b6-052638c081bb --><!-- begin field f4970ee6-d3e3-4df2-bdfb-0bb3c8993384 --><ul><li>Discussion with a specialist (for example, by telephone or email) should be considered if there is uncertainty about the interpretation of symptoms and signs, and whether a referral is needed. This may also enable the primary healthcare professional to communicate their concerns and a sense of urgency to secondary healthcare professionals when symptoms are not classical.</li><li>Put in place local arrangements to ensure that letters about non-urgent referrals are assessed by the specialist, so that the person can be seen more urgently if necessary.</li><li>Put in place local arrangements to ensure that there is a maximum waiting period for non-urgent referrals, in accordance with national targets and local arrangements.</li><li>Ensure local arrangements are in place to identify people who miss their appointments so that they can be followed up.</li><li>Include all appropriate information in referral correspondence, including whether the referral is urgent or non-urgent.</li><li>Use local referral proformas if these are in use.</li><li>Once the decision to refer has been made, make sure that the referral is made within 1 working day.</li><li>Take part in continuing education, peer review, and other activities to improve and maintain clinical consulting, reasoning, and diagnostic skills, in order to identify at an early stage people who may have cancer, and to communicate the possibility of cancer to the person.</li></ul><!-- end field f4970ee6-d3e3-4df2-bdfb-0bb3c8993384 --><!-- end item 9b825484-f933-42f2-83b6-052638c081bb -->","subChapters":[{"id":"a5870479-8071-53cb-8bf7-1a468c7ebd0c","slug":"basis-for-recommendation-586","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 85fb829c-d959-4bf8-be50-ea3e4b68dcd6 --><h4>Basis for recommendation</h4><!-- end field 85fb829c-d959-4bf8-be50-ea3e4b68dcd6 -->","summary":null,"htmlStringContent":"<!-- begin item 586997bc-6e80-448e-9c1d-1b9ead360f4e --><!-- begin field d903182b-2b81-47fb-8ce6-5a4f777e9e69 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field d903182b-2b81-47fb-8ce6-5a4f777e9e69 --><!-- end item 586997bc-6e80-448e-9c1d-1b9ead360f4e -->","subChapters":[]}]},{"id":"68391778-6ec1-5e02-991d-e5abd578be10","slug":"patient-information-support","fullItemName":"Patient information and support","depth":3,"htmlHeader":"<!-- begin field 0eb95fde-c8f1-4fd2-bfe8-e43f9b2bd9cf --><h3>What patient information and support should I offer?</h3><!-- end field 0eb95fde-c8f1-4fd2-bfe8-e43f9b2bd9cf -->","summary":null,"htmlStringContent":"<!-- begin item ef628c2c-d645-43ec-ae94-f6cd4a769388 --><!-- begin field 0a1686d5-6701-44fd-9b6f-00f4f3e3b309 --><ul><li>Discuss with people with suspected cancer (and their carers as appropriate, taking account of the need for confidentiality) their preferences for being involved in decision-making about referral options and further investigations including their potential risks and benefits.</li><li>Explain to people who are being referred with suspected cancer that they are being referred to a cancer service. Reassure them, as appropriate, that most people referred will not have a diagnosis of cancer, and discuss alternative diagnoses with them.</li><li>Give the person information on the possible diagnosis (both benign and malignant) in accordance with their wishes for information.</li><li>The information given to people with suspected cancer and their families and/or carers should cover, among other issues:<ul><li>Where the person is being referred to.</li><li>How long they will have to wait for the appointment.</li><li>How to obtain further information about the type of cancer suspected or help before the specialist appointment.</li><li>What to expect from the service the person will be attending.</li><li>What type of tests may be carried out, and what will happen during diagnostic procedures.</li><li>How long it will take to get a diagnosis or test results.</li><li>Whether they can take someone with them to the appointment.</li><li>Who to contact if they do not receive confirmation of an appointment.</li><li>Other sources of support.</li></ul></li><li>Provide information that is appropriate for the person in terms of language, ability, and culture, recognizing the potential for different cultural meanings associated with the possibility of cancer.</li><li>Have information available in a variety of formats on both local and national sources of information and support for people who are being referred with suspected cancer.</li><li>When referring a person with suspected cancer to a specialist service, assess their need for continuing support while waiting for their referral appointment. This should include inviting the person to contact their healthcare professional again if they have more concerns or questions before they see a specialist.</li><li>If the person has additional support needs because of their personal circumstances, inform the specialist (with the person's agreement).</li><li>When cancer is suspected in a child, discuss the referral decision and information to be given to the child with the parents or carers (and the child if appropriate).</li></ul><!-- end field 0a1686d5-6701-44fd-9b6f-00f4f3e3b309 --><!-- end item ef628c2c-d645-43ec-ae94-f6cd4a769388 -->","subChapters":[{"id":"e7df22ec-e89d-5c35-8c86-ae9b3c1fe9fa","slug":"basis-for-recommendation-545","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ef1fae4f-3e5d-42da-8ea0-133abb381d2a --><h4>Basis for recommendation</h4><!-- end field ef1fae4f-3e5d-42da-8ea0-133abb381d2a -->","summary":null,"htmlStringContent":"<!-- begin item 5452e699-6975-447b-b920-f9e62c7bf6bf --><!-- begin field 8ea9641d-9eea-45f5-b109-cb7f42863df9 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 8ea9641d-9eea-45f5-b109-cb7f42863df9 --><!-- end item 5452e699-6975-447b-b920-f9e62c7bf6bf -->","subChapters":[]}]},{"id":"8d3b1c02-afa5-5170-ae30-578e13b9c54e","slug":"safety-netting","fullItemName":"Safety netting","depth":3,"htmlHeader":"<!-- begin field 5cb79fd5-fba1-47d7-8232-3e9d7dc576b7 --><h3>Safety netting</h3><!-- end field 5cb79fd5-fba1-47d7-8232-3e9d7dc576b7 -->","summary":null,"htmlStringContent":"<!-- begin item c0ccc216-43fa-4ee5-8f98-445533e28ed1 --><!-- begin field a94cc763-d457-4920-af87-da892a481df8 --><ul><li>Safety netting involves active monitoring of low risk people presenting with symptoms in primary care.</li><li>Explain to people who are being offered safety netting which symptoms to look out for and when they should return for re-evaluation. It may be appropriate to provide written information.</li><li>Reassure people in the safety netting group who are concerned that they may have cancer that with their current symptoms their risk of having cancer is low.</li><li>Ensure that the results of investigations are reviewed and acted upon appropriately, with the healthcare professional who ordered the investigation taking or explicitly passing on responsibility for this. Be aware of the possibility of false-negative results for chest X-rays and tests for occult blood in faeces.</li><li>Consider a review for people with any symptom that is associated with an increased risk of cancer, but who do not meet the criteria for referral or other investigative action. The review may be planned within a time frame agreed with the person or patient-initiated if new symptoms develop, the person continues to be concerned, or their symptoms recur, persist, or worsen.</li></ul><!-- end field a94cc763-d457-4920-af87-da892a481df8 --><!-- end item c0ccc216-43fa-4ee5-8f98-445533e28ed1 -->","subChapters":[{"id":"e11a41d2-2320-5918-9f69-9ce33106cd7c","slug":"basis-for-recommendation-f84","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 9880755a-25d7-43a6-9092-506b6296782c --><h4>Basis for recommendation</h4><!-- end field 9880755a-25d7-43a6-9092-506b6296782c -->","summary":null,"htmlStringContent":"<!-- begin item f8454901-5120-44cb-a091-e757c1bc7d55 --><!-- begin field 13f6e5fe-153f-49a8-91c5-99bd0413995e --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/bone-soft-tissue-sarcoma-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 13f6e5fe-153f-49a8-91c5-99bd0413995e --><!-- end item f8454901-5120-44cb-a091-e757c1bc7d55 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}